Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblasts

James P Fabisiak1, Fei Gao, Robyn G Thomson

  • 1Department of Environmental and Occupational Health, Center for Free Radical and Antioxidant Health, University of Pittsburgh Graduate School of Public Health, College of Medicine, Pittsburgh, PA 15219-3130, USA. fabs@pitt.edu

Insights

Mycoplasma fermentans infection amplifies lung cell cytokine release, particularly IL-6, by interacting with TNF-beta. This interaction involves JNK/stress-activated protein kinase, offering insights into latent infections.

Area of Science:

  • Immunology
  • Cell Biology
  • Microbiology

Background:

  • Mycoplasma infections can lead to chronic lung disease.
  • Understanding Mycoplasma's interaction with host cells is crucial for disease management.

Purpose of the Study:

  • To investigate how Mycoplasma fermentans affects immune-modulating cytokine release in lung cells.
  • To explore the synergistic effects of M. fermentans with other immune stimuli like TNF-beta.
  • To elucidate the signaling pathways involved in M. fermentans-induced cytokine production.

Main Methods:

  • Human lung fibroblasts (HLF) were exposed to live M. fermentans and its component MALP-2.
  • Cytokine release (IL-6, IL-8/CXCL8, MCP-1/CCL2, Gro-alpha/CXCL1) was measured.
  • Synergistic effects with TNF-beta were assessed.
  • NF-kappaB activation and MAPK pathways (p38, JNK) were analyzed using inhibitors.

Main Results:

  • M. fermentans significantly increased IL-6, IL-8/CXCL8, MCP-1/CCL2, and Gro-alpha/CXCL1 production.
  • M. fermentans and TNF-beta exhibited a synergistic effect on IL-6, CXCL8, and CXCL1 release.
  • The synergistic effect was dependent on prolonged incubation and TNF-beta pre-sensitization.
  • JNK/stress-activated protein kinase was identified as crucial for amplifying IL-6 release in the combined M. fermentans and TNF-beta response.

Conclusions:

  • M. fermentans amplifies lung cell cytokine production, especially IL-6, through synergistic interactions with stimuli like TNF-beta.
  • The JNK pathway plays a key role in amplifying this synergistic cytokine response.
  • This in vitro model provides a platform for dissecting the mechanisms of Mycoplasma-host interactions in lung cells.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...